POLYMEDCO, LLC

Polymedco Cancer Diagnostic Products LLC specializes in the development, manufacture, and distribution of advanced colorectal cancer screening solutions. Their core capabilities center on the provision of Immunochemical Fecal Occult Blood Testing (IFOBT) and Fecal Immunochemical Testing (FIT) kits. The company provides a comprehensive end-to-end diagnostic ecosystem, encompassing the manufacturing of in-vitro diagnostic substances, the production of analytical laboratory instruments, and the implementation of mailed FIT programs. A key differentiator is their ability to integrate patient navigation services with diagnostic kit distribution, ensuring a seamless transition from screening to clinical follow-up. The company maintains a deep and enduring relationship with the Department of Veterans Affairs, serving as a primary provider across multiple Veterans Integrated Service Networks (VISNs). Their work for the VA focuses on large-scale diagnostic deployments, including the supply of reagents and the management of mailed screening programs for various medical centers. Additionally, they provide specialized diagnostic support to the Department of Defense and the Department of Health and Human Services, positioning them as a trusted partner for federal healthcare infrastructure. Industry focus is concentrated within the medical diagnostics and laboratory instrument manufacturing sectors. By operating across NAICS codes for analytical laboratory instrument manufacturing and in-vitro diagnostic substance manufacturing, Polymedco bridges the gap between chemical reagent production and hardware delivery. Their market positioning is highly specialized, focusing on the vertical of non-invasive cancer diagnostics and the logistical requirements of remote patient testing and medical laboratory services. Based in Cortlandt Manor, New York, Polymedco is structured as a limited liability company. The firm is positioned as a specialized niche provider within the federal healthcare market, focusing on high-volume diagnostic procurement and specialized medical supplies. While they do not hold specific socio-economic certifications, their extensive history of limited source justifications and option year exercises demonstrates a high level of technical reliability and a critical role in federal cancer screening initiatives.